Armstrong Pharms Drug Patent Portfolio
Armstrong Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Armstrong Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8367734 | Stable epinephrine suspension formulation with high inhalation delivery efficiency | 26 Jan, 2026 | Active |
Latest Legal Activities on Armstrong Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Armstrong Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Jun, 2020 | US8367734 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Feb, 2013 | US8367734 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Feb, 2013 | US8367734 |
|
Issue Notification Mailed
Critical
| 16 Jan, 2013 | US8367734 |
| Dispatch to FDC | 08 Jan, 2013 | US8367734 |
|
Application Is Considered Ready for Issue
Critical
| 07 Jan, 2013 | US8367734 |
|
Issue Fee Payment Received
Critical
| 03 Jan, 2013 | US8367734 |
|
Issue Fee Payment Verified
Critical
| 03 Jan, 2013 | US8367734 |
| Mail Miscellaneous Communication to Applicant | 27 Dec, 2012 | US8367734 |
| Printer Rush- No mailing | 19 Dec, 2012 | US8367734 |
| Miscellaneous Communication to Applicant - No Action Count | 18 Dec, 2012 | US8367734 |
|
Pubs Case Remand to TC
Critical
| 18 Dec, 2012 | US8367734 |
|
Information Disclosure Statement considered
Critical
| 11 Dec, 2012 | US8367734 |
|
Information Disclosure Statement (IDS) Filed
Critical
| 11 Dec, 2012 | US8367734 |
|
Mail Notice of Allowance
Critical
| 02 Nov, 2012 | US8367734 |
Armstrong Pharms's Family Patents
Armstrong Pharms Drug List
Given below is the complete list of Armstrong Pharms's drugs and the patents protecting them.
1. Primatene Mist
Primatene Mist is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8367734 | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
26 Jan, 2026
(1 year, 2 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Primatene Mist's drug page